Stratedigm announces the commercial launch of its A700 High Throughput Hotel.
Online PR News – 05-January-2013 – San Jose/CA – Launch of the A700 – New addition to Stratedigm Flow Cytometers: Alternative to BD LSR II and the BD Fortessa
San Jose, CA – January 04, 2012 – Stratedigm announces the commercial launch of its A700 High Throughput Hotel. The A700 complements the company’s existing line of Flow Cytometry platforms which include the A600 High Throughput Auto Sampler and Stratedigm’s suite of Flow cytometer analyzers, ranging from the entry level two laser, eight parameter SE520 model to Stratedigm’s flagship the S1000Ex, which can be configured with up to four laser and eighteen parameters.
The A700 High Throughput Hotel shares the same platform-based design philosophy utilized in Stratedigm’s existing products, allowing for a wide range of expandability and customization while offering the first fully integrated automation solution for Flow Cytometry applications.
“The A700 Hotel was designed to seamlessly integrate with our existing products while allowing intuitive, template driven experiment design and powerful data analysis and visualization using our CellCapTure software. State of the art automation features including intelligent fluidics management for long sample runs, remote system control and monitoring using any iDevice or PC, compatibility with a wide range of micro titer plates and a variety of custom tube racks make the A700 Hotel the most advanced and user friendly Flow Cytometry automation platform on the market. With the launch of the A700 Hotel, Stratedigm’s automation suite is uniquely positioned to meet the needs of the existing high throughput/high content markets in Pharma and Biotech, in addition to offering high-traffic core labs around the world the ability to have their Flow Cytometers run samples unsupervised and overnight to increase revenue and meet the needs of the growing Flow Cytometry community.
The commercial launch of the A700 Hotel marks the completion of our automation platform and the company’s transition into launching the next generation of sorters,” noted Shervin Javadi, Stratedigm’s CEO.
Stratedigm cytometers feature unmatched performance in a compact, scalable package and are adopted at prestigious core labs including Yale and Harvard and at private facilities worldwide. To learn more about Stratedigm products and how they compare to the BD LSR II and the BD Fortessa, visit www.stratedigm.com or call 408.512.3901.